Catalyst Wire Dossier Catalyst Wire Dossier

albuterol multidose dry powder inhaler

albuterol · Teva Branded Pharmaceutical Products R&D, Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for albuterol multidose dry powder inhaler, covering 2019-05-03 to 2019-08-06. Get the full timeline:

Most recent: Clinical Trial Update: Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]

See pricing